+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are exploring the use of oxandrolone, an anabolic steroid with a high anabolic to androgenic activity ratio, as a supportive treatment to improve muscle mass, strength, and functional recovery after anterior cruciate ligament ACL reconstruction surgery. This phase II, randomized, double-blind, placebo-controlled study evaluates the safety and tolerability of a subdermal bioabsorbable oxandrolone implant compared to a placebo implant over a 24-week period in men and women undergoing ACL rehabilitation. The study also examines the pharmacokinetics and serum profiles of oxandrolone delivered by this implant. Participants receive either an oxandrolone implant or a placebo implant inserted subdermally. Men assigned to the oxandrolone group receive two 200 mg implants total 400 mg, while women receive one 200 mg implant. The placebo group receives matching implants without active drug. The subdermal implant is designed to release oxandrolone directly into the bloodstream to potentially enhance muscle recovery while minimizing oral administration issues. The study includes a 24-week follow-up to monitor safety and drug delivery. Throughout the trial, participants undergo assessments including monitoring for serious adverse events and biochemical, metabolic, hormonal, and hemostasis parameters at several time points before and after implant insertion. Muscle mass, strength, and functional capacity are evaluated in an exploratory manner. Serum oxandrolone levels and pharmacokinetic measurements are collected at multiple intervals to understand drug release. The total duration of participant involvement is approximately 24 weeks, during which safety, tolerability, and exploratory efficacy outcomes are closely observed.

Age: 18Years - 60YearsAll GendersPhase 2
6 locations